FDA
-
-
-
-
-
-
-
Schrodinger (SDGR) Receives Fast Track Designation for SGR-1505 for the Treatment of Relapsed/Refractory Waldenström Macroglobulinemia
-
-
-
-
-
-
-
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities
-
-
-
-
-
-
-
Schrödinger Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Schrödinger Reports First Quarter 2022 Financial Results
-
-
-
-
-
-
-
Schrödinger Reports First Quarter 2021 Financial Results and Provides Company Update
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

